Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Amelia C A Green; Helen J Curtis; Rose Higgins; Linda Nab; Viyaasan Mahalingasivam; Rebecca M Smith; Amir Mehrkar; Peter Inglesby; Henry Drysdale; Nicholas J DeVito; Richard Croker; Christopher T Rentsch; Krishnan Bhaskaran; John Tazare; Bang Zheng; Colm D Andrews; Sebastian C J Bacon; Simon Davy; Iain Dillingham; David Evans; Louis Fisher; George Hickman; Lisa E M Hopcroft; William J Hulme; Jon Massey; Orla MacDonald; Jessica Morley; Caroline E Morton; Robin Y Park; Alex J Walker; Tom Ward; Milan Wiedemann; Christopher Bates; Jonathan Cockburn; John Parry; Frank Hester; Sam Harper; Ian J Douglas; Stephen J W Evans; Ben Goldacre; Laurie A Tomlinson; Brian MacKenna

doi:10.1136/bmjmed-2022-000276

Citation Tools

Research

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Green ACA, Curtis HJ, Higgins R, et al

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

BMJ Medicine 2023;2:e000276. doi: 10.1136/bmjmed-2022-000276

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password